Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

ANIX

Anixa Biosciences Inc

May 22 • 04:00PM ET

2.79

+0.04 1.45 %

Healthcare • Biotechnology • USA • Micro • NASD

Peers: CNTX IMNN ADAG BLRX TNXP

| Held by: VTI VXF IWC

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-0.32	Insider Own	5.38%	Shs Outstand	33.46M	Perf Week	-1.06%
Market Cap	93.54M	Forward P/E	-	EPS next Y	-0.35	Insider Trans	0.56%	Shs Float	31.72M	Perf Month	-8.22%
Enterprise Value	78.30M	PEG	-	EPS next Q	-0.09	Inst Own	15.28%	Short Float	3.27%	Perf Quarter	-4.78%
Income	-10.31M	P/S	-	EPS this Y	1.47%	Inst Trans	-2.10%	Short Ratio	9.50	Perf Half Y	-35.86%
Sales	0.00M	P/B	6.19	EPS next Y	-4.48%	ROA	-60.39%	Short Interest	1.04M	Perf YTD	-10.58%
Book/sh	0.45	P/C	6.59	EPS next 5Y	-3.32%	ROE	-62.61%	52W High	5.46 -48.87%	Perf Year	7.31%
Cash/sh	0.42	P/FCF	-	EPS past 3/5Y	9.05% 5.67%	ROIC	-67.69%	52W Low	2.44 14.34%	Perf 3Y	-19.13%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	4.46% 5.32%	Perf 5Y	-30.94%
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	19.02%	Oper. Margin	-	ATR (14)	0.15	Perf 10Y	-9.71%
Dividend Ex-Date	-	Quick Ratio	12.18	Sales Y/Y TTM	-	Profit Margin	-	RSI (14)	45.29	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	12.18	EPS Q/Q	21.94%	SMA20	-4.40%	Beta	0.63	Target Price	11.50
Payout	-	Debt/Eq	0.01	Sales Q/Q	-	SMA50	-1.41%	Rel Volume	0.37	Prev Close	2.75
Employees	4	LT Debt/Eq	0.01	Earnings	Mar 13	SMA200	-16.46%	Avg Volume	109.07K	Price	2.79
IPO	Oct 07, 1983	Option/Short	Yes / Yes	EPS/Sales Surpr.	10.21% -	Trades		Volume	40,492	Change	1.45%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)